title: Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group.
authors.affiliation: University of Pennsylvania Cancer Center, Philadelphia.
authors.forename: P A
authors.initials: PA
authors.lastname: Cassileth
authors.forename: D P
authors.initials: DP
authors.lastname: Harrington
authors.forename: J D
authors.initials: JD
authors.lastname: Hines
authors.forename: M M
authors.initials: MM
authors.lastname: Oken
authors.forename: J J
authors.initials: JJ
authors.lastname: Mazza
authors.forename: P
authors.initials: P
authors.lastname: McGlave
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: E
authors.initials: E
authors.lastname: Lynch
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Connell
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000677:Amsacrine / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013866:Thioguanine / Q000008:administration & dosage; D014481:United States / Q000453:epidemiology
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin